Advertisement

The Latest

Fifty-nine percent of healthcare executives said in a recent survey that physician specialists are the most difficult clinical job to fill, but the specialty that is most difficult for systems varies by state. Hospitals and health systems are grappling with…

Carl Cameron was promoted to executive vice president and COO of Holyoke, Mass.-based Holyoke Medical Center and Valley Health Systems, according to a May 20 news release shared with Becker’s. Mr. Cameron joined Holyoke Medical Center in 2001 and has…

In 2026, the U.S. prescription drug market is predicted to exceed $1 trillion for the first time, and GLP-1 drugs such as Ozempic, Zepbound and Wegovy are the primary drivers of this growth.   GLP-1s accounted for 14% of U.S. drug…

Cardiovascular service lines are growing fast—and so are the data streams they are expected to manage. The remote monitoring landscape—once confined to pacemakers and ICDs—has diversified to include Holter monitors, MCTs, loop recorders, and FDA-approved wearables. Yet, this proliferation of…

This episode recorded live at the Becker’s 16th Annual Meeting features Andrew Mueller, Chief Executive Officer, MaineHealth. He discusses reducing the total cost of care, responding to demographic and technological shifts, and how MaineHealth is balancing innovation, workforce engagement, and…

Virginia Governor Abigail Spanberger has vetoed two bills that would have created a prescription drug pricing system in the state, arguing similar models in other states have failed to lower drug costs. The legislation, House Bill 483 and Senate Bill…

States are advancing legislation to restrict how pharmacy benefit managers operate. In doing so, they are targeting practices such as steering patients to PBM-owned pharmacies, spread pricing, and opaque rebate arrangements that critics say inflate drug costs while squeezing independent…

Advertisement